Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ContraFect
company
About
ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $7.20M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. It addresses multi-drug resistant infections using therapeutic products from its lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. Its novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills bacteria.
The company was founded in 2008 and is headquartered in Yonkers, New York.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$11.52M
ContraFect has raised a total of
$11.52M
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2019 | Grant | $7.20M | 1 |
|
— | Detail |
| Aug 23, 2010 | Series Unknown | $4.32M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
ContraFect is funded by 2 investors.
Congressionally Directed Medical Research Programs
and Equity Source Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
|
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
